Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | 3 | G-CSF | 9.5 | 58 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 9.0 | 77 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | G-CSF | 9.0 | 75 | ||||
RA2159 | 3 | G-CSF | 11.0 | 89 | |||||||
N2586 | 3 | G-CSF | 8.5 | 52 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | G-CSF | 11.0 | 62 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | G-CSF | 11.0 | 59 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | G-CSF | 12.0 | 60 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 12.0 | 73 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | G-CSF | 11.0 | 54 | ||||
N2586 | 3 | G-CSF | 13.0 | 53 | |||||||
RA2159 | Visfatin | 1 | ng/mL | 3 | G-CSF | 14.0 | 64 | ||||
RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 12.0 | 69 | |
RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 10.5 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 12.0 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 10.0 | 72 | |
RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 11.0 | 73 | |
N2586 | Visfatin | 1 | ng/mL | 3 | G-CSF | 12.0 | 50 | ||||
N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 12.0 | 73 | |
N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 13.0 | 71 | |
N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 14.0 | 46 | |
N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 10.0 | 65 | |
N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | G-CSF | 10.0 | 67 | |
RA2159 | Leptin | 1 | ng/mL | 3 | G-CSF | 11.5 | 76 | ||||
RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | G-CSF | 13.0 | 83 |